Cronos Group Inc (CRON) - Market Cap to Net Income

Cronos Group Inc - graphic logo of issuer CRON

Outsourcing raw material cultivation while maintaining full branding control drives the P/E fundamental multiple for Cronos Group Inc. (CRON), where the metric currently stands at 22.00. High industry cyclicality and regulatory dependence make market share a higher priority than current profits. Stable management and significant cash reserves ensure the financial resilience of Cronos Group Inc. (CRON) during periods of volatility.

thecronosgroup.com (CRON): Price to Earnings Ratio from 07/04/2022 to 11/12/2026

Comprehensive metric breakdowns and analytics for Cronos (CRON)

- share price and expert price forecast:
Price Performance Chart thecronosgroup.com|CRON - Analyst Consensus Forecast
- market capitalization indicators:
Market Valuation Cronos Group Inc.|CRON - Enterprise Value
- business book valuation details:
Book Value per Share Cronos Group|CRON - Company Book Value|Market Value to Book Value thecronosgroup.com|CRON - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Cronos Group Inc.|CRON - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Cronos Corp|CRON - Company Debts|Debt to Net Assets Ratio Cronos Group Inc.|CRON - Company Long-Term Debt|Short-Term Debt Cronos Group|Immediate Liquidity Ratio thecronosgroup.com
- net income and valuation ratios data:
CRON - Company Net Income|Expected Net Profit Cronos Group Inc.|CRON - Price to Earnings Ratio|Market Cap to Projected Earnings Cronos Group Inc|CRON - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Cronos Group Inc.|CRON - Operating profit EBITDA|Net earnings per share for the trailing year Cronos Group|CRON - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months thecronosgroup.com|CRON - Earnings per share growth in current year|Expected net earnings per share growth next year Cronos Group Inc.
Comprehensive company analysis:thecronosgroup.com - CRON
Signature product of Cronos Group Inc.

The ratio of market capitalization to net income determines the investment payback period, allowing investors to filter out speculative noise and benchmark business stability against industry standards. Cronos Group Inc. (CRON) investments in energy-efficient greenhouses and ESG standards impact profitability, which is reflected in the company's annual P/E dynamics as an indicator of the asset's fundamental value.

Analysis of competing companies

INDV: Company Value to Net Income|P/E Multiple COLL|CGC: Market Cap to Net Income|P/E Multiple HITI (High Tide Corp)|P/E Multiple Aurora Cannabis, Inc. ACB|ACHV - Price to Earnings Ratio|Company Value to Net Income SKYE (skyebioscience.com)|Anebulo Pharmaceuticals, Inc. (ANEB) - Price to Earnings Ratio|Price to Earnings Ratio InterCure|NTRB (Nutriband Inc) - P/E Multiple|Price to Earnings Ratio Nasus Pharma, Ltd. (NSRX)|Price to Earnings Ratio IGC Pharma, Inc. (IGC)|MIRA (mirapharmaceuticals.com) - Company Value to Net Income|Price to Earnings Ratio Flora Growth FLGC|IM Cannabis Corp (IMCC) - Market Cap to Earnings|ADIL - Price to Earnings Ratio|ARTL (Artelo Biosciences) - Price to Earnings Multiple|ensysce.com (ENSC) - Price to Earnings Ratio|Market Cap to Earnings Titan Pharmaceuticals, Inc. (TTNP)|Price to Earnings Ratio Greenlane|InMed Pharmaceuticals Inc (INM) - Business Payback Period|Price to Earnings Ratio AKAN (Akanda Corporation)|ENVB (Enveric Corp) - Company Value to Net Income|P/E Multiple BGXX (Bright Green Corporation)|Market Cap to Net Income Ratio Hempacco Co Inc.